EUVIMEDEUVIMED entdecken
Crossref

TGFβ4 alleviates the phenotype of Charcot–Marie–Tooth disease type 1A

Hyeonjin Jeon, So Young Jang, Geon Kwak, Yong Weon Yi, Mi-Hyeon You, Na Young Park, Ju Hee Jo, Ji Won Yang, Hye Ji Jang, Sun-Young Jeong, Seung Kee Moon, Hyun Myung Doo und 5 weitere

Brain · 2023

DOI: 10.1093/brain/awad147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Hyeonjin Jeon und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan 49201, Korea. Hauptthemen laut MEDLINE: Charcot-Marie-Tooth Disease. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Korean Health Technology, Ministry of Health & Welfare, Ministry of Science and ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The duplication of the peripheral myelin protein 22 (PMP22) gene causes a demyelinating type of neuropathy, commonly known as Charcot–Marie–Tooth disease type 1A (CMT1A). Development of effective drugs for CMT1A still remains as an unmet medical need. In the present study, we assessed the role of the transforming growth factor beta 4 (TGFβ4)/Nodal axis in the pathogenesis of CMT1A. First, we identified PMP22 overexpression-induced Nodal expression in Schwann cells, which might be one of the downstream effectors in CMT1A. Administration of Nodal protein at the developmental stage of peripheral nerves induced the demyelinating phenotype in vivo. Second, we further isolated TGFβ4 as an antagonist that could abolish Nodal-induced demyelination. Finally, we developed a recombinant TGFβ4–fragment crystallizable (Fc) fusion protein, CX201, and demonstrated that its application had promyelinating efficacy in Schwann cells. CX201 administration improved the demyelinating phenotypes of CMT1A mouse models at both pre-symptomatic and post-symptomatic stages. These results suggest that the TGFβ4/Nodal axis plays a crucial role in the pathogenesis of CMT1A and might be a potential therapeutic target for CMT1A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Charcot-Marie-Tooth DiseaseAnimalsMiceMyelin ProteinsSchwann CellsPhenotypeTransforming Growth Factor beta

Stichwörter der Autor:innen

Charcot–Marie–Tooth disease (CMT)Nodaldemyelinationperipheral myelin protein 22 (PMP22)transforming growth factor beta 4 (TGFβ4)

Substanzen

Myelin ProteinsTransforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan 49201, Korea.
  • Dementia Research Group, Korea Brain Research Institute, Daegu 41062, Korea.
  • Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Korea.
  • BioMedicine Lab., CKD Research Institute, ChongKunDang Pharm., Yongin 16995, Korea.
  • Department of Biochemistry, College of Medicine, Dankook University, Cheonan 31116, Korea.
  • Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Förderung

  • Korean Health Technology
  • Ministry of Health & Welfare
  • Ministry of Science and ICT
  • National Research Facilities
  • Ministry of Education

Zitieren

APA

Jeon, H., Jang, S. Y., Kwak, G., Yi, Y. W., You, M. H., Park, N. Y., Jo, J. H., Yang, J. W., Jang, H. J., Jeong, S. Y., Moon, S. K., Doo, H. M., Nahm, M., Kim, D., Chang, J. W., Choi, B. O., & Hong, Y. B. (2023). TGFβ4 alleviates the phenotype of Charcot–Marie–Tooth disease type 1A. Brain. https://doi.org/10.1093/brain/awad147

Vancouver

Jeon H, Jang SY, Kwak G, Yi YW, You MH, Park NY, et al. TGFβ4 alleviates the phenotype of Charcot–Marie–Tooth disease type 1A. Brain. 2023. doi:10.1093/brain/awad147

BibTeX
@article{Jeon2023,
  author = {Jeon, Hyeonjin and Jang, So Young and Kwak, Geon and Yi, Yong Weon and You, Mi-Hyeon and Park, Na Young and Jo, Ju Hee and Yang, Ji Won and Jang, Hye Ji and Jeong, Sun-Young and Moon, Seung Kee and Doo, Hyun Myung and Nahm, Minyeop and Kim, Donghoon and Chang, Jong Wook and Choi, Byung-Ok and Hong, Young Bin},
  title = {TGFβ4 alleviates the phenotype of Charcot–Marie–Tooth disease type 1A},
  journal = {Brain},
  year = {2023},
  doi = {10.1093/brain/awad147}
}
Kostenlos starten →